Zydus Cadila says 'positive results' from phase 2 studies of COVID-19 drug Desidustat in Mexico
In June 2020, Zydus Cadila had received approval from Mexico's
regulatory authority Cofepris to test one of its lead research
candidate Desidustat in the management of COVID-19.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-says-positive-results-from-phase-2-studies-of-covid-19-drug-desidustat-in-mexico/articleshow/80444749.cms
regulatory authority Cofepris to test one of its lead research
candidate Desidustat in the management of COVID-19.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-says-positive-results-from-phase-2-studies-of-covid-19-drug-desidustat-in-mexico/articleshow/80444749.cms
Comments
Post a Comment